Recurrence analysis has emerged as a pivotal framework for understanding the intricate behaviour of complex dynamical systems. By constructing visual representations known as recurrence plots, ...
Thanks to modern, multimodal breast cancer therapies, 5-year local recurrence rates following lumpectomy have dropped significantly, making breast-conserving surgery (BCS) an option for more patients ...
The role of adjuvant chemotherapy in stage II colon cancer continues to be debated. The presence of circulating tumor DNA (ctDNA) after surgery predicts very poor recurrence-free survival, whereas its ...
-- 80% or greater reduction in metastatic breast cancer recurrence rate over 5 years of follow-up with a peak immune response at 6 months and well-tolerated safety profile. -- The PIS elicited a ...
A retrospective analysis shows that low postoperative thyroglobulin levels are associated with a low risk for recurrence in ...
Recurrence beyond Milan criteria predicts worse outcomes after hepatocellular carcinoma resection. Limited recurrence remains ...
The Young Women's Breast Cancer Study is a prospective cohort of women diagnosed with breast cancer at age ≤ 40 years and enrolled patients between 2006 and 2016 (N = 1,302). We identified patients ...
Blue light cystoscopy reduces bladder cancer recurrence risk by 38% compared to white light cystoscopy, as shown in the BRAVO study. The BRAVO study used real-world data from 626 veterans, confirming ...
A new tool can help physicians determine which patients with localized pancreatic neuroendocrine tumors (PanNETs) have an ...
Recurrence risk for stage II to III colon cancer falls below 0.5% 6 years posttreatment, suggesting a potential cure definition. The study analyzed data from 15 phase 3 trials, involving 35,213 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback